First-Line Chemotherapy vs Bowel Tumor Resection Plus Chemotherapy for Patients With Unresectable Synchronous Colorectal Hepatic Metastases

作者: Gennaro Galizia , Eva Lieto , Michele Orditura , Paolo Castellano , Vincenzo Imperatore

DOI: 10.1001/ARCHSURG.143.4.352

关键词:

摘要: Hypothesis Bowel resection followed by chemotherapy is a better management strategy than immediate in asymptomatic patients with colorectal cancer and unresectable liver-only metastases at presentation. Design Retrospective study. Setting University hospital. Patients Sixty-five consecutive symptom-free synchronous confined to the liver undergoing bowel tumor plus systemic (42 [resection group]) or first (23 [chemotherapy group]). Main Outcome Measures Long-term survival identification of prognostic indicators outcome. Results In group, mean median overall times were shown be significantly those group ( P  = .03). Performance status, basal serum levels lactic dehydrogenase alkaline phosphatase, percentage involvement, potentially curative tumor, type treatment (resection vs chemotherapy) demonstrated only variables correlated long-term survival. On multivariate analysis, performance extent covariates independently associated rate. The rate metastasis downstaging subsequent hepatic was clearly good limited tumor. Conclusions Achieving complete cure appears mostly result shrinkage metastases. status best option for this purpose.

参考文章(28)
C D A Wolfe, K S Raju, M C Shaw, O Devaja, Development of an evidence-based algorithm for the management of ovarian cancer. European Journal of Gynaecological Oncology. ,vol. 24, pp. 117- 125 ,(2003)
Sylvain Manfredi, C??me Lepage, Cyril Hatem, Olivier Coatmeur, Jean Faivre, Anne-Marie Bouvier, Epidemiology and management of liver metastases from colorectal cancer. Annals of Surgery. ,vol. 244, pp. 254- 259 ,(2006) , 10.1097/01.SLA.0000217629.94941.CF
Mark L Sundermeyer, Neal J Meropol, André Rogatko, Hao Wang, Steven J Cohen, None, Changing patterns of bone and brain metastases in patients with colorectal cancer. Clinical Colorectal Cancer. ,vol. 5, pp. 108- 113 ,(2005) , 10.3816/CCC.2005.N.022
Seth A. Rosen, Initial Presentation With Stage IV Colorectal Cancer Archives of Surgery. ,vol. 135, pp. 530- 534 ,(2000) , 10.1001/ARCHSURG.135.5.530
Charles R. Scoggins, Ingrid M. Meszoely, Charles D. Blanke, R. Daniel Beauchamp, Steven D. Leach, Nonoperative management of primary colorectal cancer in patients with stage IV disease. Annals of Surgical Oncology. ,vol. 6, pp. 651- 657 ,(1999) , 10.1007/S10434-999-0651-X
Pierre Michel, Isabelle Roque, Frédéric Di Fiore, Sophie Langlois, Michel Scotte, Paul Tenière, Bernard Paillot, Colorectal cancer with non-resectable synchronous metastases: should the primary tumor be resected? Gastroenterologie Clinique Et Biologique. ,vol. 28, pp. 434- 437 ,(2004) , 10.1016/S0399-8320(04)94952-4
N. Chafai, C. L. H. Chan, E. L. Bokey, O. F. Dent, G. Sinclair, P. H. Chapuis, What factors influence survival in patients with unresected synchronous liver metastases after resection of colorectal cancer Colorectal Disease. ,vol. 7, pp. 176- 181 ,(2005) , 10.1111/J.1463-1318.2004.00744.X
Robert C. Flanigan, Sydney E. Salmon, Brent A. Blumenstein, Scott I. Bearman, Vivek Roy, Patrick C. McGrath, John R. Caton, Nikhil Munshi, E. David Crawford, Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. The New England Journal of Medicine. ,vol. 345, pp. 1655- 1659 ,(2001) , 10.1056/NEJMOA003013
Vijay P. Khatri, Nicholas J. Petrelli, Jacques Belghiti, Extending the Frontiers of Surgical Therapy for Hepatic Colorectal Metastases: Is There a Limit? Journal of Clinical Oncology. ,vol. 23, pp. 8490- 8499 ,(2005) , 10.1200/JCO.2004.00.6155